Filing Flows › Cosmos Health (COSM) › Q1 2026 › vs Q4 2025
Cosmos Health (COSM) Q1 2026 vs Q4 2025 (quarter over quarter)
Cosmos Health's revenue fell $1.8M (-9%) from $19.7M in Q4 2025 to $17.9M in Q1 2026. The biggest changes: Wholesale −$1.8M (-10%); Nutraceuticals and Pharmaceuticals +$280K (+54%); Pharma manufacturing −$237K (-50%).
Cosmos Health, Q1 2026: revenue $17.9M (+31% year over year), operating margin -12.2%, net loss $2.8M, operating cash flow −$1.1M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Wholesale | $16.9M | $18.7M | −$1.8M | -10% |
| Nutraceuticals and Pharmaceuticals | $796K | $517K | $280K | +54% |
| Pharma manufacturing | $238K | $476K | −$237K | -50% |
| Other | $485 | $1K | −$338 | -41% |
| Revenue | $17.9M | $19.7M | −$1.8M | -9% |
| Net loss | $2.8M | $10.1M | −$7.3M | -72% |
| Costs & expenses | $20.7M | $31.1M | −$10.4M | -33% |
| Operating costs | $20.1M | $31.1M | −$11.0M | -35% |
| Interest & other, net | $621K | −$1.3M | $1.9M | — |
| Cost of revenue | $16.5M | $17.6M | −$1.1M | -6% |
| Sales & marketing | $19K | $36K | −$16K | -46% |
| General & admin | $1.8M | $10.6M | −$8.8M | -83% |
| Other operating costs | $1.7M | $2.4M | −$684K | -28% |
| Operating cash sources | $2.8M | $10.1M | −$7.3M | -72% |
| Depreciation & amortization | $347K | $315K | $31K | +10% |
| Share-based compensation | $536K | $582K | −$46K | -8% |
| Working capital & other | $856K | $4.7M | −$3.8M | -82% |
| Cash used in operations | $1.1M | $4.6M | −$3.5M | -77% |
| Net loss absorbed | $2.8M | $10.1M | −$7.3M | -72% |
Questions
How much did Cosmos Health's revenue grow quarter over quarter in Q1 2026?
Cosmos Health's revenue fell $1.8M (-9%) from $19.7M in Q4 2025 to $17.9M in Q1 2026.
What drove Cosmos Health's revenue change in Q1 2026?
Wholesale −$1.8M (-10%); Nutraceuticals and Pharmaceuticals +$280K (+54%); Pharma manufacturing −$237K (-50%).